
HGTV star Jasmine Roth shares major health update after daughter's severe sleep apnea diagnosis
In a heartfelt update shared through an interview with Future of Personal Health, Roth revealed that five-year-old Hazel underwent tonsil and adenoid reduction surgery in November 2023.
And now, Hazel is doing much better.
'Hazel is sleeping like a champ!' Roth shared. 'She has no issues, just goes to sleep, sleeps through the night, and wakes up in the morning, which anybody with a child knows is a big deal.'
Jasmine admitted she had no idea children could even experience sleep apnea.
Hazel showed signs as early as six months old, but the condition remained undiagnosed until she was three.
The diagnosis came years after going undetected, despite heavily affecting the entire family's sleep and wellbeing.
In an Instagram post from November 2023, Roth spoke about her daughter Hazel's journey after she was first diagnosed of pediatric sleep apnea.
It happened after a sleep study confirmed she had borderline severe sleep apnea, which caused her to wake up more than seven times per hour and experience drops in oxygen levels.
Before her diagnosis, Jasmine and her husband Brett noticed something was off.
'A few months ago, we noticed a weird breathing/snorting thing happening,' Roth shared on Instagram at the time.
Despite Hazel seeming to sleep fine at times, a visit to a pediatric ENT specialist and a follow-up sleep study revealed the severity of her condition.
Jasmine recalled, 'Her tonsils were touching… and the x-rays showed her adenoids were also enlarged.'
Choosing surgery wasn't a decision they made lightly.
'We opted to do a sleep study instead of jumping right into surgery,' she wrote.
But after the results came in, it became clear that surgical intervention was the best path forward.
It was found that Hazel's tonsils were touching and that her adenoids were enlarged
She praised the care Hazel received at CHOC Children's Hospital and the compassion shown by the medical staff.
'If I ever need surgery, I want to go there,' she said, giving a special shoutout to Dr. Bhatt and the team.
The surgery was a success.
Just weeks later, Hazel began sleeping soundly through the night - for the first time in her life.
'Like most parents, we wish we'd caught it sooner,' Roth said. 'But once we understood what was going on, everything moved quickly.'
In the midst of this health scare, the Roth family also experienced a joyful - though intense - milestone.
In September 2024, Jasmine gave birth to their second daughter, Darla, one month early in what she described as a dramatic, near-roadside delivery.
Roth shared that the surgery was a success and that Hazel was sleeping through the night for the first time in her life
Thankfully, the new addition arrived as Hazel's health was already improving drastically.
After spending 15 days in the NICU, Darla is now healthy and bonding with her big sister.
With so many personal developments, it's no surprise Jasmine took a step back from filming Help! I Wrecked My House over the past year.
But fans won't have to wait much longer as a new season, filmed in the Roths' new home state of Utah, is set to premiere sometime in Fall 2025.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mail
3 hours ago
- Daily Mail
Menopause made my hair fall out. Then I discovered a new hair-loss solution. This is the secret ALL midlife women need to know
For me, midlife has brought various indignities, as well as many joys. But standing over a sink to count the number of hairs that had come out in my brush one morning has to be among the more distressing aspects. For the record, it was 201. And why was I counting them? Because I'd searched 'how to tell if your hair is falling out' online – and according to Dr Google, anything over 100 strands was a cause for concern.


The Independent
4 hours ago
- The Independent
WeightWatchers boss says ‘exciting work to do' amid impact of weight loss jabs
WeightWatchers was slower to adapt to the emergence of anti-obesity jabs than rivals, its boss has admitted, as the 62-year-old brand strives to catch up with rapidly evolving attitudes towards weight loss. Tara Comonte, chief executive of the US-based business, said it had a lot of work to do after going through a 'reset'. WeightWatchers recently announced it had emerged from bankruptcy after writing off a portion of the 1.15 billion US dollar (£860 million) debt on its balance sheet. It came as the business was competing with the emergence of GLP-1s – the scientific term for weight loss jabs, which work by reducing food cravings – and a new wave of apps and advice spreading on social media. Ms Comonte told the PA news agency that it 'wasn't as quick to medical weight loss solutions' as some other firms in the US, notably so-called 'telehealth' businesses that offer healthcare remotely. WeightWatchers, which runs some 20,000 workshops each month globally, is now 'at the beginning of the journey' towards forging a new place in the industry and meeting demand from current and future members, Ms Comonte said. 'This whole industry is going through somewhat of a reset and we have exciting work to do,' she told the PA news agency. 'This is a moment where, possibly more than ever before, people are talking about weight, and weight health… where people are seeking more education than ever before, and there are more voices than ever before.' Ms Comonte said the brand was known for 'trust and science' and it was important to harness that 'as there are more and more voices in the ecosystem'. WeightWatchers recently partnered with anti-obesity drugs provider CheqUp in the UK so patients taking the medication can access its 'companion' diet and lifestyle support app. It forms part of its efforts to muscle into the market by offering behavioural strategies and community-based support to people using or coming off the medication. 'There's no 'us and them' anymore,' Ms Comonte told PA, hitting back at weight loss jabs often being pitted as rivals to its model. Dr Kim Boyde, WeightWatchers' newly appointed chief medical officer, said not all its members will want or need weight loss medication – but stressed that it was 'imperative' the programme offers it to those that might benefit. Recent estimates suggest that about 1.5 million people in the UK are taking weight loss jabs. Health officials have suggested that they can help to turn the tide on obesity, but have stressed they are not a silver bullet and do come with side effects.


Reuters
5 hours ago
- Reuters
Roche to investigate whether new drug can delay or prevent Alzheimer's disease
July 27 (Reuters) - Swiss drugmaker Roche Holding (ROG.S), opens new tab plans to investigate whether an experimental medicine can delay or prevent Alzheimer's disease symptoms, it said on Sunday, as a part of the company's growing development programme for the disease. The clinical trial of the drug, Trontinemab, will target people who are at risk of cognitive decline and will aim to delay or prevent the symptoms of Alzheimer's, Roche said in a statement. Trontinemab is designed so that the drug is transported across the blood brain barrier—protective blood vessels that prevent chemicals in the bloodstream from entering the brain — in hopes of delivering more of the treatment to the brain. Rivals like Eli Lilly (LLY.N), opens new tab have been making progress in the complicated field of Alzheimer's recently, with Lilly's drug Kisunla getting a recommendation for approval for certain patients from the European Medicines Agency last week. Kisunla is already approved in the U.S. Treatments for Alzheimer's approved so far, including Eisai (4523.T), opens new tab and Biogen's (BIIB.O), opens new tab Leqembi and Lilly's Kisunla, are designed to clear sticky clumps of a protein called amyloid beta in the brain. They carry hefty price tags as well as the risk of serious brain swelling and bleeding.